Multimodal deep learning for immunotherapy response prediction and biomarker discovery in non-small cell lung cancer
{{output}}
Objective: Immunotherapy has emerged as a promising treatment for advanced non-small cell lung cancer (NSCLC), but accurately predicting which patients will benefit from it remains a major clinical challenge. To address this, we ... ...
